IRIS
CARACCIOLO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.072
EU - Europa 671
AS - Asia 519
SA - Sud America 98
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 2.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.039
IT - Italia 388
SG - Singapore 309
CN - Cina 125
DE - Germania 97
BR - Brasile 80
GB - Regno Unito 67
SE - Svezia 33
FI - Finlandia 30
CA - Canada 25
HK - Hong Kong 23
IN - India 22
NL - Olanda 13
FR - Francia 10
VN - Vietnam 8
EU - Europa 7
RU - Federazione Russa 7
ZA - Sudafrica 7
AT - Austria 6
BD - Bangladesh 6
JP - Giappone 6
AR - Argentina 5
ES - Italia 5
MX - Messico 5
EC - Ecuador 4
AU - Australia 3
CZ - Repubblica Ceca 3
IQ - Iraq 3
PY - Paraguay 3
TR - Turchia 3
UA - Ucraina 3
VE - Venezuela 3
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
ID - Indonesia 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
KE - Kenya 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 2.382
Salva come PNG Salva come JPEG
Città #
Singapore 190
Chandler 152
Munich 71
Santa Clara 69
Hefei 66
Dallas 65
Ashburn 62
Chicago 50
London 47
Catanzaro 44
Lawrence 44
Princeton 44
Milan 43
Turku 22
Hong Kong 20
Naples 19
Wilmington 18
Los Angeles 17
Beijing 15
Rome 15
New York 14
Des Moines 13
Ottawa 13
Carbonia 12
Parma 12
Brooklyn 11
São Paulo 10
Boardman 9
Cosenza 8
Ercolano 8
Helsinki 8
Redwood City 8
San Nicola Manfredi 8
Santo Stefano di Rogliano 8
Afragola 7
Boston 6
Melito di Porto Salvo 6
Montreal 6
Stockholm 6
Catania 5
Columbus 5
Guangzhou 5
Manchester 5
Reggio Calabria 5
Seattle 5
Settingiano 5
Shanghai 5
The Dalles 5
Brescia 4
Charlotte 4
Chennai 4
Decollatura 4
Dhaka 4
Hanover 4
Jiaxing 4
Johannesburg 4
Mountain View 4
New Delhi 4
Pune 4
Redmond 4
Acquaviva delle Fonti 3
Ahmedabad 3
Berlin 3
Cape Town 3
Castrovillari 3
Denver 3
Frankfurt am Main 3
Mileto 3
Nuremberg 3
Olomouc 3
Palermo 3
Paola 3
Phoenix 3
San Antonio 3
San Francisco 3
Treviso 3
Washington 3
6th of October City 2
Agrigento 2
Andover 2
Assago 2
Atlanta 2
Beirut 2
Bismarck 2
Bologna 2
Brighton 2
Buffalo 2
Campina Grande 2
Campinas 2
Campobello di Licata 2
Caracas 2
Ceglie Del Campo 2
Council Bluffs 2
Delhi 2
Esslingen am Neckar 2
Gesuiti 2
Grottaglie 2
Ho Chi Minh City 2
Jackson 2
Juiz de Fora 2
Totale 1.436
Salva come PNG Salva come JPEG
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 107
miR-22 suppresses DNA ligase III addiction in multiple myeloma 90
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 89
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 74
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 72
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 66
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 60
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 58
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 53
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 52
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 51
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 51
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 50
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 49
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 48
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 46
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 45
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 44
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 44
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 43
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 43
Mir-221/222 are promising targets for innovative anticancer therapy 42
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 42
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 42
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 41
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 39
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 39
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 39
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 39
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 39
Mmrf-commpass data integration and analysis for identifying prognostic markers 38
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 38
Integration of DNA Microarray with Clinical and Genomic Data 38
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 37
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 37
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 36
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 34
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 34
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 34
Alternative non-homologous end-joining: Error-prone dna repair as cancer’s achilles’ heel 33
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma 32
null 31
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 31
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 31
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 28
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 27
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 26
Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma 24
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 23
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 23
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches 23
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 23
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 22
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 22
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma. 20
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 19
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma 19
The potential role of miRNAs in multiple myeloma therapy 19
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts 19
The potential role of miRNAs in multiple myeloma therapy 18
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity 17
Synthetic miR-22 impairs NHEJ repair sensistizing multiple myeloma cells to bortezomib-induced BRCAness 16
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 15
Immunomodulatory activity of microRNAs: potential implications for multiple myeloma treatment. 14
Targeting oncogenic pri-miR-17-92 in multiple myeloma: molecular findings and therapeutic potential 14
Totale 2.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 0 9 10 12 9 11 10 25 20 15 5
2021/2022179 4 0 0 27 7 5 11 30 37 31 24 3
2022/2023541 95 29 32 21 64 38 6 39 76 54 68 19
2023/2024320 86 32 36 22 16 83 7 6 1 5 10 16
2024/2025886 88 26 29 37 59 132 39 45 70 10 130 221
2025/2026405 111 184 110 0 0 0 0 0 0 0 0 0
Totale 2.512